Health Resources and Services Administration (HRSA): AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)

All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands are eligible to apply for funding if they meet the above requirement.

States/territories that did not report to HRSA a new ADAP waiting list or use the ADAP ERF to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2018 are not eligible to apply.

ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health insurance assistance). HRSA will base ADAP awards upon applicants’ ability to successfully demonstrate need for additional funding. An external objective review committee (ORC) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists.

HRSA first funded the ERF initiative in August 2010, when numerous states/territories were experiencing ADAP waiting lists. At the time of publication of this NOFO, there are no ADAP waiting lists. HRSA continues to provide funding under this initiative to maintain infrastructure in those states/territories that had previously imposed waiting lists, and to ensure that no new waiting lists are established. States/territories that have not reported an existing waiting list to HRSA must do so immediately and use funding awarded under this NOFO to remove clients from the waiting list.

Applicants are encouraged to consider how their proposed activities with the ADAP ERF funding support HRSA’s emphasis on innovation, collaboration, impact, and effectiveness.